Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00469573 · ClinicalTrials.gov registry record · Phase 4
Safety and Efficacy of Optive in Contact Lens Wearers With Dry Eyes
A Phase 4 study, sponsored by Innovative Medical.
- Completed
- Registry status
- Phase 4
- Development phase
- 36
- Enrollment target
NCT00469573 is a Phase 4 study that has completed, run by Innovative Medical. The registered enrollment target is 36 participants.
The verdict
NCT00469573, a Phase 4 study, has completed, sponsored by Innovative Medical.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 36 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if Optive®eye drops are safe for people who wear contact lenses and have dry eyes. The second goal of the study is to determine if using Optive®eye drops can improve my dry eye scores on a standard dry eye test (called the OSDI).
Interventions
- DRUG 1. Optive
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2007-05 |
| Est. Completion | 2008-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00469573
The ClinicalTrials.gov registry entry for NCT00469573 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Innovative Medical, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 1. Optive is the first listed.
NCT00469573 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00469573 about?
NCT00469573 is a clinical study titled "Safety and Efficacy of Optive in Contact Lens Wearers With Dry Eyes". The purpose of this study is to determine if Optive®eye drops are safe for people who wear contact lenses and have dry eyes. The second goal of the study is to determine if using Optive®eye drops can improve my dry eye scores on a standard dry eye test (called the OSDI).
What is the current status of trial NCT00469573?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 36 participants. The study started on 2007-05. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00469573?
The interventions under investigation include: 1. Optive (DRUG).
Who is sponsoring clinical trial NCT00469573?
This trial is sponsored by Innovative Medical, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.